Actively Recruiting
Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia
Led by Dr. Nazanin Alavi · Updated on 2024-10-18
60
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
D
Dr. Nazanin Alavi
Lead Sponsor
O
Online PsychoTherapy Clinic
Collaborating Sponsor
AI-Summary
What this Trial Is About
Insomnia is defined as the inability to fall asleep or stay asleep at night and it is one of the most prevalent sleep disorders that can have deleterious impacts on health and this population's quality of life. Currently, both pharmaceutical interventions (trazodone) and cognitive behavioral therapy (CBTi) are widely used to treat patients with insomnia. Although CBTi has been efficacious in many patients, multitude of barriers for receiving treatment such as its limited availability of therapists, high costs and long wait times challenge its ability in sufficiently meeting the population's health needs and demands. To improve the delivery of CBT, electronically delivered CBTi (e-CBTi) has been developed as an accessible and effective alternative intervention for improving sleep outcomes in patients with insomnia. While evidence suggest that e-CBTi is effective when compared to placebos/waitlist control, evidence comparing guided e-CBTi to pharmaceutical interventions is still insufficient and needs further exploration.
CONDITIONS
Official Title
Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age at the start of the study
- Diagnosed with non-organic insomnia
- Difficulty initiating or maintaining sleep for 30 minutes or more
- Use of sleep-promoting medication at least three nights per week for at least 3 months
- Ability to speak and read English
- Consistent and reliable access to the internet
You will not qualify if you...
- Presence of another untreated sleep disorder
- Alcohol or substance use disorder
- Ongoing cognitive-behavioral therapy
- Untreated or unassessed significant somatic or mental symptoms or illnesses
- Other sleep disorders that could explain insomnia symptoms or interfere with or be worsened by e-CBTi
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen's University
Kingston, Ontario, Canada, K7L5G2
Actively Recruiting
Research Team
N
Nazanin Alavi, MD FRCPC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here